calcipotriene and betamethasone dipropionate
calcipotriene and betamethasone dipropionate is listed in the FDA National Drug Code directory with 4 NDC codes, marketed under brand names including calcipotriene and betamethasone dipropionate, Attero, TACLONEX. Available dosage forms: suspension, solution, aerosol, foam.
Drug Details
- Generic Name
- calcipotriene and betamethasone dipropionate
- Brand Names
- calcipotriene and betamethasone dipropionate, Attero, TACLONEX, ENSTILAR
- Application Number
- ANDA210765
- Sponsor
- Cosette Pharmaceuticals, Inc.
- NDC Codes
- 4
- Dosage Forms
- SUSPENSION, SOLUTION, AEROSOL, FOAM
- Routes
- TOPICAL
- Active Ingredients
- BETAMETHASONE DIPROPIONATE, CALCIPOTRIENE, CALCIPOTRIENE HYDRATE, CALCIPOTRIENE MONOHYDRATE
Indications and Usage
1 INDICATIONS AND USAGE Taclonex ® Topical Suspension is indicated for the topical treatment of plaque psoriasis of the scalp and body in patients 12 years and older. Taclonex Topical Suspension is a combination of calcipotriene, a vitamin D analog, and betamethasone dipropionate, a corticosteroid, indicated for the topical treatment of plaque psoriasis of the scalp and body in patients 12 years and older. ( 1 )